Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.

Anderson AM, Chane T, Patel M, Chen S, Xue W, Easley KA.

AIDS Patient Care STDS. 2012 Aug;26(8):454-62. doi: 10.1089/apc.2012.0068. Epub 2012 Jun 28.

2.

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium.

Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.

PMID:
18657012
3.

A probable interaction between warfarin and the antiretroviral TRIO study regimen.

Liedtke MD, Vanguri A, Rathbun RC.

Ann Pharmacother. 2012 Nov;46(11):e34. doi: 10.1345/aph.1R290. Epub 2012 Oct 31.

PMID:
23115227
4.

Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.

Chitsike RS, Rodger MA, Kovacs MJ, Betancourt MT, Wells PS, Anderson DR, Chagnon I, LE Gal G, Solymoss S, Crowther MA, Perrier A, White RH, Vickars LM, Ramsay T, Kahn SR.

J Thromb Haemost. 2012 Oct;10(10):2039-44. doi: 10.1111/j.1538-7836.2012.04872.x.

5.

Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.

Di Biagio A, Prinapori R, Giannarelli D, Maggiolo F, Di Giambenedetto S, Borghi V, Penco G, Cicconi P, Francisci D, Sterrantino G, Zoncada A, Monno L, Capetti A, Giacometti A; ARCA Collaborative Group.

J Antimicrob Chemother. 2013 Jan;68(1):200-5. doi: 10.1093/jac/dks339. Epub 2012 Aug 21.

PMID:
22915463
6.
7.

Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.

Wong YM, Quek YN, Tay JC, Chadachan V, Lee HK.

J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12.

PMID:
21070296
8.

A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.

Meijer K, Kim YK, Carter D, Schulman S.

Thromb Haemost. 2011 Feb;105(2):232-8. doi: 10.1160/TH10-05-0324. Epub 2010 Dec 21.

PMID:
21173999
9.

Epidemiology of subtherapeutic anticoagulation in the United States.

Rose AJ, Ozonoff A, Grant RW, Henault LE, Hylek EM.

Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):591-7. doi: 10.1161/CIRCOUTCOMES.109.862763. Epub 2009 Sep 22.

10.

Warfarin initiation nomograms for venous thromboembolism.

Garcia P, Ruiz W, Loza Munarriz C.

Cochrane Database Syst Rev. 2013 Jul 10;(7):CD007699. doi: 10.1002/14651858.CD007699.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;(1):CD007699.

PMID:
23839808
11.
12.

Venous Thromboembolism Requiring Extended Anticoagulation Among HIV-Infected Patients in a Rural, Resource-Constrained Setting in Western Kenya.

Kanyi J, Karwa R, Pastakia SD, Manji I, Manyara S, Saina C.

Ann Pharmacother. 2017 May;51(5):380-387. doi: 10.1177/1060028016686106. Epub 2017 Jan 6.

PMID:
28056524
13.

Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence?

Cohen AT, Maillardet L, Yavin Y.

Thromb Haemost. 2009 Mar;101(3):422-7.

PMID:
19277401
14.

Search for predictors of nontherapeutic INR results with warfarin therapy.

McGriff-Lee NJ, Csako G, Chen JT, Dang DK, Rosenfeld KG, Cannon RO, Macklin LR, Wesley RA; Anticoagulation Working Group.

Ann Pharmacother. 2005 Dec;39(12):1996-2002. Epub 2005 Nov 15.

PMID:
16288081
15.
16.

Prevalent aetiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics.

Cryder B, Felczak M, Janociak J, Dela Pena L, Allen S, Gutierrez P.

J Clin Pharm Ther. 2011 Feb;36(1):64-70. doi: 10.1111/j.1365-2710.2009.01155.x.

PMID:
21198721
17.

The efficacy of 3-mg warfarin initiating dose in adult Thai patients, who required long-term anticoagulant therapy.

Suwanawiboon B, Kongtim P, Chinthammitr Y, Ruchutrakool T, Wanachiwanawin W.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S225-31.

PMID:
21721451
18.

A potential interaction between warfarin and atovaquone.

Hidalgo K, Lyles A, Dean SR.

Ann Pharmacother. 2011 Jan;45(1):e3. doi: 10.1345/aph.1P491. Epub 2010 Dec 28.

PMID:
21189363
19.

Potential interaction involving warfarin and ritonavir.

Knoell KR, Young TM, Cousins ES.

Ann Pharmacother. 1998 Dec;32(12):1299-302.

PMID:
9876810
20.

Outpatient management of anticoagulation therapy.

du Breuil AL, Umland EM.

Am Fam Physician. 2007 Apr 1;75(7):1031-42. Review.

Supplemental Content

Support Center